Aller au contenu principal

 Articles scientifiques

A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.

Auteurs : Gourari K, Catherine J, Garaud S, Kerger J, Lepida A, Georgala A, Lebrun F, Gomez Galdon M, Gil T, Willard-Gallo K, Langouo Fontsa M
Année : 2022
Journal : Diagnostics (Basel)
Volume : 12

Persistent anti-tumor response in cancer patients experiencing pneumonitis related to immune checkpoint blockade.

Auteurs : Belcaid L, Garaud S, Kerger J, Spyridon S, Aspeslagh S
Année : 2021
Journal : Acta Clin Belg
Volume : 76
Pages : 144-148

A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder.

Auteurs : Wang X, Suppa M, Bruderer P, Sirtaine N, Aspeslagh S, Kerger J
Année : 2021
Journal : Case Rep Oncol
Volume : 14
Pages : 861-867

Characterization and Clinical Utility of <i>BRAF</i><sup>V600</sup> Mutation Detection Using Cell-Free DNA in Patients with Advanced Melanoma.

Auteurs : Rutkowski P, Pauwels P, Kerger J, Jacobs B, Maertens G, Gadeyne V, Thielemans A, de Backer K, Neyns B
Année : 2021
Journal : Cancers (Basel)
Volume : 13

Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.

Auteurs : Bregni G, Sticca T, Camera S, Akin Telli T, Craciun L, Trevisi E, Pretta A, Kehagias P, Leduc S, Senti C, Deleporte A, Vandeputte C, Saad ED, Kerger J, Gil T, Piccart-Gebhart M, Awada A, Demetter P, Larsimont D, Hendlisz A, Aftimos P, Sclafani F
Année : 2020
Journal : Acta oncol (Stockholm)
Volume : 59
Pages : 1438-1446

Immunotherapy in gynecological cancers: where are we?

Auteurs : Polastro L, Closset C, Kerger J
Année : 2020
Journal : Curr Opin Oncol
Volume : 32
Pages : 459-470

Pimasertib Versus Dacarbazine in Patients With Unresectable <i>NRAS</i>-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.

Auteurs : Lebbé C, Dutriaux C, Lesimple T, Kruit W, Kerger J, Thomas L, Guillot B, Braud F, Garbe C, Grob JJ, Loquai C, Ferraresi V, Robert C, Vasey P, Conry R, Isaacs R, Espinosa E, Schueler A, Massimini G, Dréno B
Année : 2020
Journal : Cancers (Basel)
Volume : 12

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Auteurs : Liberale G, Pop FC, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Année : 2020
Journal : J Visc Surg
Volume : 157
Pages : 79-86

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance.

Auteurs : Krayem M, Aftimos P, Najem A, van den Hooven T, van den Berg A, Hovestad-Bijl L, de Wijn R, Hilhorst R, Ruijtenbeek R, Sabbah M, Kerger J, Awada A, Journe F, Ghanem G
Année : 2020
Journal : Cancers (Basel)
Volume : 12

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. <i>

Auteurs : Krayem M, Aftimos P, Najem A, Hooven TVD, Berg AVD, Hovestad-Bijl L, Wijn R, Hilhorst R, Ruijtenbeek R, Sabbah M, Kerger J, Awada A, Journe F, Ghanem G
Année : 2020
Journal : Cancers (Basel)
Volume : 12

Treatment algorithm in patients with ovarian cancer.

Auteurs : Vergote I, Denys H, De Greve J, Gennigens C, Van de Vijver K, Kerger J, Vuylsteke P, Baurain JF
Année : 2020
Journal : Facts Views Vis Obgyn
Volume : 12
Pages : 227-239

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.

Auteurs : Naumann RW, Hollebecque A, Meyer T, Devlin MJ, Oaknin A, Kerger J, López-Picazo JM, Machiels JP, Delord JP, Evans TRJ, Boni V, Calvo E, Topalian SL, Chen T, Soumaoro I, Li B, Gu J, Zwirtes R, Moore KN
Année : 2019
Journal : J Clin Oncol
Volume : 37
Pages : 2825-2834

New Drug Combination Strategies in Melanoma: Current Status and Future Directions.

Auteurs : Najem A, Krayem M, Perdrix A, Kerger J, Awada A, Journe F, Ghanem G
Année : 2017
Journal : Anticancer Res
Volume : 37
Pages : 5941-5953

Recurrence dynamics of breast cancer according to baseline body mass index.

Auteurs : Biganzoli E, Desmedt C, Fornili M, de Azambuja E, Cornez N, Ries F, Closon-Dejardin MT, Kerger J, Focan C, Di Leo A, Nogaret JM, Sotiriou C, Piccart-Gebhart M, Demicheli R
Année : 2017
Journal : Eur J Cancer
Volume : 87
Pages : 10-20

Is there still a role for cytotoxic chemotherapy after targeted therapy and immunotherapy in metastatic melanoma? A case report and literature review.

Auteurs : Simon A, Kourie HR, Kerger J
Année : 2017
Journal : Chin J Cancer
Volume : 36
Pages : 10

Brain metastases: an unusual dissemination of heterologous carcinosarcoma of the uterus

Auteurs : El Hachem G, Jungels C, de Wind R, Kerger J
Année : 2017
Journal : Belgian J Medical Oncology
Volume : 11(6)
Pages : 284-288

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.

Auteurs : Dhondt V, Goffin F, Roca L, Dresse D, Leroy C, Kerger J, Cordier L, de Forges H, Veys I, Liberale G
Année : 2016
Journal : Int J Gynecol Cancer
Volume : 26(5)
Pages : 912-7

Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib.

Auteurs : Draganova D, Kerger J, Caspers L, Willermain F
Année : 2015
Journal : J Ophthalmic Inflamm Infect
Volume : 5
Pages : 17

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up.

Auteurs : Dallaudière B, Kerger J, Malghem J, Galant C, Lecouvet FE
Année : 2015
Journal : Acta Radiol Open
Volume : 4(2)
Pages : 2047981614552217

Notwithstanding the fact that no breaking, practice changing studies were presented in the sessions devoted to gynaecological cancers at this years' annual ESMO meeting, the strong trend towards targeted therapies was confirmed, in accordance with th

Auteurs : Kerger J
Année : 2014
Journal : Belgian J Medical Oncology
Volume : 8(4)
Pages : 147-51